JP2012502061A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012502061A5 JP2012502061A5 JP2011526247A JP2011526247A JP2012502061A5 JP 2012502061 A5 JP2012502061 A5 JP 2012502061A5 JP 2011526247 A JP2011526247 A JP 2011526247A JP 2011526247 A JP2011526247 A JP 2011526247A JP 2012502061 A5 JP2012502061 A5 JP 2012502061A5
- Authority
- JP
- Japan
- Prior art keywords
- active ingredient
- composition
- composition according
- hours
- zein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 28
- 239000004480 active ingredient Substances 0.000 claims 21
- 238000000034 method Methods 0.000 claims 11
- 229920002494 Zein Polymers 0.000 claims 8
- 239000008188 pellet Substances 0.000 claims 8
- 239000005019 zein Substances 0.000 claims 8
- 229940093612 zein Drugs 0.000 claims 8
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims 6
- 229920000881 Modified starch Polymers 0.000 claims 6
- 239000000463 material Substances 0.000 claims 6
- 239000008108 microcrystalline cellulose Substances 0.000 claims 6
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims 6
- 229940016286 microcrystalline cellulose Drugs 0.000 claims 6
- 238000013268 sustained release Methods 0.000 claims 6
- 239000012730 sustained-release form Substances 0.000 claims 6
- 239000008187 granular material Substances 0.000 claims 5
- 238000002156 mixing Methods 0.000 claims 5
- 239000006185 dispersion Substances 0.000 claims 4
- 238000000338 in vitro Methods 0.000 claims 4
- 239000011248 coating agent Substances 0.000 claims 3
- 239000008199 coating composition Substances 0.000 claims 3
- 238000000576 coating method Methods 0.000 claims 3
- 239000000126 substance Substances 0.000 claims 3
- CBOJBBMQJBVCMW-BTVCFUMJSA-N (2r,3r,4s,5r)-2-amino-3,4,5,6-tetrahydroxyhexanal;hydrochloride Chemical compound Cl.O=C[C@H](N)[C@@H](O)[C@H](O)[C@H](O)CO CBOJBBMQJBVCMW-BTVCFUMJSA-N 0.000 claims 2
- TVYLLZQTGLZFBW-ZBFHGGJFSA-N (R,R)-tramadol Chemical compound COC1=CC=CC([C@]2(O)[C@H](CCCC2)CN(C)C)=C1 TVYLLZQTGLZFBW-ZBFHGGJFSA-N 0.000 claims 2
- 241001465754 Metazoa Species 0.000 claims 2
- DYWNLSQWJMTVGJ-KUSKTZOESA-N Phenylpropanolamine hydrochloride Chemical compound Cl.C[C@H](N)[C@H](O)C1=CC=CC=C1 DYWNLSQWJMTVGJ-KUSKTZOESA-N 0.000 claims 2
- 235000013869 carnauba wax Nutrition 0.000 claims 2
- 239000004203 carnauba wax Substances 0.000 claims 2
- 238000004090 dissolution Methods 0.000 claims 2
- 238000001035 drying Methods 0.000 claims 2
- 238000010828 elution Methods 0.000 claims 2
- 238000010438 heat treatment Methods 0.000 claims 2
- 239000008172 hydrogenated vegetable oil Substances 0.000 claims 2
- 229940060367 inert ingredients Drugs 0.000 claims 2
- 229910052500 inorganic mineral Inorganic materials 0.000 claims 2
- 239000007788 liquid Substances 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 238000002844 melting Methods 0.000 claims 2
- 230000008018 melting Effects 0.000 claims 2
- 239000011707 mineral Substances 0.000 claims 2
- 229960002305 phenylpropanolamine hydrochloride Drugs 0.000 claims 2
- 238000002560 therapeutic procedure Methods 0.000 claims 2
- 229960004380 tramadol Drugs 0.000 claims 2
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 claims 1
- 229920001287 Chondroitin sulfate Polymers 0.000 claims 1
- 208000017667 Chronic Disease Diseases 0.000 claims 1
- 206010021639 Incontinence Diseases 0.000 claims 1
- 230000036528 appetite Effects 0.000 claims 1
- 235000019789 appetite Nutrition 0.000 claims 1
- 230000004888 barrier function Effects 0.000 claims 1
- 229940059329 chondroitin sulfate Drugs 0.000 claims 1
- 230000007812 deficiency Effects 0.000 claims 1
- 235000005911 diet Nutrition 0.000 claims 1
- 230000000378 dietary effect Effects 0.000 claims 1
- 239000002552 dosage form Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229960001911 glucosamine hydrochloride Drugs 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 238000004513 sizing Methods 0.000 claims 1
- TVYLLZQTGLZFBW-GOEBONIOSA-N tramadol Natural products COC1=CC=CC([C@@]2(O)[C@@H](CCCC2)CN(C)C)=C1 TVYLLZQTGLZFBW-GOEBONIOSA-N 0.000 claims 1
- 239000011782 vitamin Substances 0.000 claims 1
- 229940088594 vitamin Drugs 0.000 claims 1
- 229930003231 vitamin Natural products 0.000 claims 1
- 235000013343 vitamin Nutrition 0.000 claims 1
Images
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9436308P | 2008-09-04 | 2008-09-04 | |
| US61/094,363 | 2008-09-04 | ||
| PCT/US2009/056103 WO2010028290A1 (en) | 2008-09-04 | 2009-09-04 | Chewable sustained release formulations |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012502061A JP2012502061A (ja) | 2012-01-26 |
| JP2012502061A5 true JP2012502061A5 (enExample) | 2012-09-20 |
| JP5608653B2 JP5608653B2 (ja) | 2014-10-15 |
Family
ID=41219093
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011526247A Expired - Fee Related JP5608653B2 (ja) | 2008-09-04 | 2009-09-04 | チュアブルな徐放性製剤 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US10668012B2 (enExample) |
| EP (1) | EP2331076B1 (enExample) |
| JP (1) | JP5608653B2 (enExample) |
| CN (1) | CN102202654B (enExample) |
| AU (1) | AU2009289464B2 (enExample) |
| CA (1) | CA2736119C (enExample) |
| ES (1) | ES2536736T3 (enExample) |
| WO (1) | WO2010028290A1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1400578B1 (it) * | 2010-06-18 | 2013-06-14 | Alpex Pharma Sa | Processo per la preparazione di compresse a rilascio controllato. |
| AU2012345726B2 (en) * | 2011-12-02 | 2017-04-13 | Pegasus Laboratories, Inc. | Amphipathic lipid-based sustained release compositions |
| US10722458B2 (en) * | 2011-12-02 | 2020-07-28 | Pegasus Laboratories, Inc. | Amphipathic lipid-based sustained release compositions |
| AU2013257546B2 (en) | 2012-05-10 | 2017-12-14 | Painreform Ltd. | Depot formulations of a local anesthetic and methods for preparation thereof |
| CN103686676A (zh) * | 2012-08-31 | 2014-03-26 | 中兴通讯股份有限公司 | 设备到设备通信系统的通信方法、装置及系统 |
| WO2014047362A1 (en) * | 2012-09-19 | 2014-03-27 | Phyto Tech Corp. | Compositions and methods for improving or preventing depression-like symptoms |
| EP2968569A4 (en) | 2013-03-15 | 2016-11-02 | Argenta Mfg Ltd | COUGAR FORMULATION |
| US11173135B2 (en) | 2016-03-17 | 2021-11-16 | Thiogenesis Therapeutics, Inc. | Compositions for controlled release of cysteamine and systemic treatment of cysteamine sensitive disorders |
| JP6800596B2 (ja) * | 2016-03-29 | 2020-12-16 | 小林製薬株式会社 | 錠剤 |
| EP3519812A4 (en) * | 2016-09-27 | 2020-06-17 | Zolentroff, William C. | ALA AND SALT FORMULATION |
| CA3049952A1 (en) * | 2017-07-26 | 2019-01-31 | Tgx Soft Chew, Llc | Starch-free soft chew for veterinary applications |
| CN109420163B (zh) * | 2017-08-23 | 2022-06-21 | 中山市力恩普制药有限公司 | 治疗呼吸道感染的药物组合物及其制备方法和用途 |
| CN118924717A (zh) | 2017-09-20 | 2024-11-12 | 硫创治疗公司 | 用于治疗半胱胺敏感性病症的方法 |
| WO2020136620A1 (en) * | 2018-12-29 | 2020-07-02 | 3M Innovative Properties Company | Oral articles and methods of use |
| US20220080019A1 (en) * | 2018-12-29 | 2022-03-17 | 3M Innovative Properties Company | Oral articles and methods of use |
| CN111744018A (zh) * | 2019-03-26 | 2020-10-09 | 北京福元医药股份有限公司 | 一种盐酸氨基葡萄糖药物制剂 |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3567819A (en) * | 1969-01-30 | 1971-03-02 | Hoffmann La Roche | Cold tablet |
| US5032406A (en) * | 1989-02-21 | 1991-07-16 | Norwich Eaton Pharmaceuticals, Inc. | Dual-action tablet |
| GB8913889D0 (en) * | 1989-06-16 | 1989-08-02 | May & Baker Ltd | New compositions of matter |
| US5182130A (en) * | 1989-11-06 | 1993-01-26 | Opta Food Ingredients, Inc. | Method for producing an edible prolamine coating from an aqueous latex |
| US5077053A (en) * | 1990-02-12 | 1991-12-31 | Warner-Lambert Company | Zein as a moisture barrier for sugarless edible compositions and method for preparing same |
| US5599556A (en) * | 1991-12-31 | 1997-02-04 | Abbott Laboratories | Prolamine coatings for taste masking |
| US6210714B1 (en) * | 1993-11-23 | 2001-04-03 | Euro-Celtique S.A. | Immediate release tablet cores of acetaminophen having sustained-release coating |
| US5965161A (en) * | 1994-11-04 | 1999-10-12 | Euro-Celtique, S.A. | Extruded multi-particulates |
| DE19630035A1 (de) * | 1996-07-25 | 1998-01-29 | Asta Medica Ag | Tramadol Multiple Unit Formulierungen |
| JP3877083B2 (ja) * | 1996-08-03 | 2007-02-07 | 昭和産業株式会社 | 第４胃以降消化・吸収性反芻動物用飼料製剤並びにそれを含有する反芻動物用飼料 |
| FR2752732B1 (fr) * | 1996-08-28 | 1998-11-20 | Pf Medicament | Forme galenique a liberation prolongee de milnacipran |
| US5904937A (en) * | 1997-10-03 | 1999-05-18 | Fmc Corporation | Taste masked pharmaceutical compositions |
| AU747549B2 (en) * | 1998-03-23 | 2002-05-16 | General Mills Inc. | Encapsulation of components into edible products |
| US7815937B2 (en) * | 1998-10-27 | 2010-10-19 | Biovail Laboratories International Srl | Quick dissolve compositions and tablets based thereon |
| WO2001032148A1 (en) * | 1999-10-29 | 2001-05-10 | Euro-Celtique, S.A. | Controlled release hydrocodone formulations |
| US6277409B1 (en) * | 2000-02-11 | 2001-08-21 | Mcneil-Ppc, Inc. | Protective coating for tablet |
| US20020106408A1 (en) * | 2000-12-01 | 2002-08-08 | Johnatan Bacon | Prolamin-based sustained-release compositions and delayed-onset compositions |
| DE50113344D1 (de) * | 2001-01-31 | 2008-01-17 | Evonik Roehm Gmbh | Multipartikuläre arzneiform, enthaltend mindestens zwei unterschiedlich überzogene pelletformen |
| US20030228368A1 (en) * | 2001-09-28 | 2003-12-11 | David Wynn | Edible solid composition and dosage form |
| US7612112B2 (en) * | 2001-10-25 | 2009-11-03 | Depomed, Inc. | Methods of treatment using a gastric retained gabapentin dosage |
| CA2489295A1 (en) * | 2002-06-27 | 2004-01-08 | Cilag Ag | Spherical pellet containing a water-soluble active ingredient |
| US7399488B2 (en) * | 2002-07-05 | 2008-07-15 | Collegium Pharmaceutical, Inc. | Abuse-deterrent pharmaceutical compositions of opiods and other drugs |
| GB2403407B (en) * | 2003-07-03 | 2006-12-13 | Michael Hilary Burke | Palatable oral anthelmintic composition |
| JP2007509155A (ja) * | 2003-10-21 | 2007-04-12 | アルファーマ インコーポレイテッド | クエチアピンを含有する薬剤 |
| US20050089558A1 (en) * | 2003-10-28 | 2005-04-28 | Alamo Pharmaceuticals, Llc | Compositions and methods for the co-formulation and administration of tramadol and propoxyphene |
| PL2486942T3 (pl) * | 2004-11-24 | 2019-05-31 | Meda Pharmaceuticals Inc | Kompozycje zawierające azelastynę oraz sposoby ich stosowania |
| JP4050784B2 (ja) | 2005-02-03 | 2008-02-20 | 株式会社Ｎｒｌファーマ | マトリックス型腸溶性・徐放性組成物 |
| JP4602949B2 (ja) * | 2006-08-02 | 2010-12-22 | 和光堂株式会社 | 被覆粒子含有組成物及びその製造方法 |
-
2009
- 2009-09-04 JP JP2011526247A patent/JP5608653B2/ja not_active Expired - Fee Related
- 2009-09-04 CN CN200980143789.3A patent/CN102202654B/zh not_active Expired - Fee Related
- 2009-09-04 US US12/554,361 patent/US10668012B2/en active Active
- 2009-09-04 ES ES09792287.6T patent/ES2536736T3/es active Active
- 2009-09-04 WO PCT/US2009/056103 patent/WO2010028290A1/en not_active Ceased
- 2009-09-04 CA CA2736119A patent/CA2736119C/en active Active
- 2009-09-04 AU AU2009289464A patent/AU2009289464B2/en not_active Ceased
- 2009-09-04 EP EP09792287.6A patent/EP2331076B1/en not_active Not-in-force
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012502061A5 (enExample) | ||
| CN102202654B (zh) | 可咀嚼的缓释制剂 | |
| AU2008223091B2 (en) | Sustained release pellets comprising wax-like material | |
| EP0785775B2 (en) | Melt-extruded orally administrable opioid formulations | |
| JP6240279B2 (ja) | 制御放出ヒドロコドン処方 | |
| TW200427448A (en) | Controlled release preparations comprising tramadol and topiramate | |
| WO2011037976A2 (en) | Pramipexole pharmaceutical formulations | |
| CN103520130B (zh) | 孟鲁斯特钠择时控释片及其制备方法 | |
| CN103520136B (zh) | 孟鲁斯特钠脉冲胶囊及其制备方法 | |
| CN101947209A (zh) | 双丙戊酸钠小丸及其制备方法 | |
| KR20090047310A (ko) | 덱시부프로펜을 함유하는 다층정제 | |
| CN103222968A (zh) | 一种含有氟尼辛葡甲胺的片剂及其制备方法 | |
| CN101537005B (zh) | 可待因和氯苯那敏复方缓释胶囊 | |
| KR20080075113A (ko) | 에스시탈로프람 및 부프로피온을 함유하는 안정한 약학적제형 | |
| CN116350596A (zh) | 利培酮速释缓释双释放制剂及其制备方法 | |
| CN101234095A (zh) | 一种定时释放制剂及其制备方法 | |
| HK1141441B (en) | Sustained release pellets comprising wax-like material | |
| JP2006089461A (ja) | 覚醒剤原料含有レイアリング顆粒 | |
| HK1069110B (en) | Melt-extruded orally administrable opioid formulations | |
| HK1069109B (en) | Melt-extruded orally administrable opioid formulations | |
| MXPA06003040A (es) | Proceso para la obtencion de esferas recubiertas de ketorolaco, composicion farmaceutica y uso. |